Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Therapeutic monitoring of immunosuppressive drugs: Where do we stand? (CROSBI ID 227138)

Prilog u časopisu | stručni rad

Granić, Paula ; Lalić, Zdenka Therapeutic monitoring of immunosuppressive drugs: Where do we stand? // Neurologia Croatica. Supplement, 61 (2012), 161-165

Podaci o odgovornosti

Granić, Paula ; Lalić, Zdenka

engleski

Therapeutic monitoring of immunosuppressive drugs: Where do we stand?

In the first half of the 20th century, attempts at transplantation of organs were unsuccessful because there were no clear ideas about the processes of immune response. With the advances in immunology, immunosuppressive drugs were developed. Initially, it was thought that successful immunosuppression can be achieved only by achieving complete immunodeficiency. Today we are entering an era in which the aim of a standard combination therapy will be no more to suppress the immune system, but to modulate it. Eff ective, safe and cost-eff ective therapy requires dosage individualization based on therapeutic drug monitoring.

cyclosporine; everolimus; immunosuppressive drugs; mycophenolic acid; sirolimus; tacrolimus; therapeutic drug monitoring

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

61

2012.

161-165

objavljeno

1331-5196

Povezanost rada

Kliničke medicinske znanosti, Farmacija